2474亿元!中国创新药“销冠”落定

谈思生物
Oct 19

根据市场统计,从2016年上半年至2025年上半年,阿斯利康在中国创新药公立医疗机构销售中稳居首位,累计销售额达2474亿元,是唯一一家销售总额超过2000亿元的药企。01市场霸主的成绩单2016年初至2025年中期,国内公立医院创新药销售榜TOP10清一色由外资药企占据,拜耳、辉瑞、赛诺菲、罗氏、诺华等巨头悉数登场,前七家销售额全部跨过千亿门槛;其中,阿斯利康以2474亿元遥遥领先,是唯一一家...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10